Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
NKGen Biotech, Inc. - Common Stock
(NQ:
NKGN
)
0.7713
+0.0079 (+1.03%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about NKGen Biotech, Inc. - Common Stock
< Previous
1
2
3
Next >
Why Is PTC Therapeutics (PTCT) Stock Down 23% Today?
October 27, 2023
PTC Therapeutics stock is falling on Friday as PTCT investors react to the company's lackluster earnings report for Q3 2023.
Via
InvestorPlace
Why Is TransCode Therapeutics (RNAZ) Stock Down 25% Today?
October 27, 2023
TransCode Therapeutics stock is falling on Friday after the company announced plans for a public offering of RNAZ shares.
Via
InvestorPlace
Why Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
October 27, 2023
Gainers NKGen Biotech, Inc. (NASDAQ: NKGN) shares surged 60.9% to $6.08 in pre-market trading after gaining 8% on Thursday. NKGen Biotech presented Phase I clinical trial data at the 16th Annual...
Via
Benzinga
Why Is Apollomics (APLM) Stock Up 113% Today?
October 27, 2023
Apollomics stock is taking off on Friday with heavy trading of APLM following its latest study news presented to traders yesterday.
Via
InvestorPlace
Why Is NKGen Biotech (NKGN) Stock Up 18% Today?
October 27, 2023
NKGen Biotech stock is taking off on Friday as NKGN investors react to the company's clinical trial results for its Alzheimer’s treatment.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
October 27, 2023
It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday!
Via
InvestorPlace
NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.
October 24, 2023
Via
Get News
Exposures
Product Safety
NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.
October 24, 2023
--News Direct--
Via
News Direct
Exposures
Product Safety
NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.
October 24, 2023
SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics,...
Via
TheNewswire.com
Exposures
Product Safety
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 17, 2023
It's time for another dive into the biggest pre-market stock movers as we list out the top stocks worth watching on Tuesday!
Via
InvestorPlace
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 05, 2023
Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent...
Via
Benzinga
Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
October 05, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
October 05, 2023
Pre-market stock movers are rising and falling on Thursday as we check out all of the latest news worth knowing about this morning!
Via
InvestorPlace
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.